Depression, medical illness, and interleukin-1beta in older cardiac patients

J M Lyness1, J A Moynihan, D J Williford

  • 1Department of Psychiatry, University of Rochester Medical Center, New York 14642, USA. Jeffrey_Lyness@urmc.rochester.edu

Insights

Interleukin-1 beta (IL-1beta) levels were not linked to depression in cardiac patients. This cytokine was, however, associated with overall medical illness burden, suggesting a general sickness response rather than a specific link to depression.

Area of Science:

  • Immunology
  • Psychiatry
  • Cardiology

Background:

  • Atherosclerosis is hypothesized to contribute to late-life depression via cytokine effects on monoamine systems.
  • Pilot data is needed to investigate the association between interleukin-1 beta (IL-1beta) and depression in cardiac patients.

Purpose of the Study:

  • To test the hypothesis that serum IL-1beta levels are associated with depression in a cardiac patient group.

Main Methods:

  • Thirty-seven cardiac patients underwent evaluations for depression diagnosis (Structured Clinical Interview for DSM-III-R) and symptom severity (Hamilton Rating Scale for Depression).
  • Medical illness burden was assessed using the Cumulative Illness Rating Scale.
  • Serum IL-1beta levels were quantified using enzyme-linked immunosorbent assay.

Main Results:

  • Serum IL-1beta levels showed no significant association with depressive symptom severity or depression diagnosis, even after controlling for medical illness burden, age, and gender.
  • A significant positive correlation was observed between IL-1beta levels and medical illness burden.

Conclusions:

  • The study did not confirm the hypothesis linking IL-1beta to depression in cardiac patients.
  • The correlation between IL-1beta and medical illness burden likely represents a general "sickness response" to various disease states.
  • Further research with larger sample sizes and non-cardiac comparison groups is recommended.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...